This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pain management company AlgoRx Pharmaceuticals raised $65mm through a Series C financing led by new investor Advent International. Returning backers InterWest Partners, JPMorgan Partners, and Sofinnova Ventures participated in the oversubscribed round along with additional new investors SR One, Pacific Rim Ventures, Index Ventures, Lehman Brothers Healthcare Fund, Hunt Ventures, EGS Healthcare Capital Partners, Piper Jaffray Ventures, NIF Ventures, Axiom Venture Partners, Cogene Biotech Ventures, and William Harris Investors.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?